These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19728929)

  • 1. Effects of transdermal estrogen therapy on expressions of estrogen receptors and T-lymphocyte apoptosis in surgically menopausal women.
    Zhang J; Chen X; Zhang S; Zhou G; Xia X; Lu L
    Cell Mol Immunol; 2009 Aug; 6(4):277-83. PubMed ID: 19728929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women.
    Xia X; Zhang S; Yu Y; Zhao N; Liu R; Liu K; Chen X
    J Reprod Immunol; 2009 Jul; 81(1):89-96. PubMed ID: 19497624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women.
    Kumru S; Godekmerdan A; Yilmaz B
    J Reprod Immunol; 2004 Aug; 63(1):31-8. PubMed ID: 15284002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do different delivery systems of estrogen therapy influence serum lipids differently in surgically menopausal women?
    Baksu B; Davas I; Agar E; Akyol A; Uluocak A
    J Obstet Gynaecol Res; 2007 Jun; 33(3):346-52. PubMed ID: 17578365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
    Baksu B; Baksu A; Göker N; Citak S
    Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.
    Kling JM; Dowling NM; Bimonte-Nelson HA; Gleason CE; Kantarci K; Manson JE; Taylor HS; Brinton EA; Lobo RA; Cedars MI; Pal L; Neal-Perry G; Naftolin F; Harman SM; Miller VM
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R912-R920. PubMed ID: 31663769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes.
    Mor G; Sapi E; Abrahams VM; Rutherford T; Song J; Hao XY; Muzaffar S; Kohen F
    J Immunol; 2003 Jan; 170(1):114-22. PubMed ID: 12496390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin levels in menopausal women on long-term estrogen implants.
    Goh HH; McCarthy TG; Dramusic V; Ratnam SS
    Gynecol Endocrinol; 1989 Jun; 3(2):153-7. PubMed ID: 2510462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive performance in surgically menopausal women on estrogen.
    Verghese J; Kuslansky G; Katz MJ; Sliwinski M; Crystal HA; Buschke H; Lipton RB
    Neurology; 2000 Sep; 55(6):872-4. PubMed ID: 10994013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy for cognitive function in postmenopausal women.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Estrogen Efficacy Against Hippocampus Damage in Long-Term OVX Mice Is Related to the Reduction of Hippocampus Local Estrogen Production and Estrogen Receptor Degradation.
    Ma Y; Liu M; Yang L; Zhang L; Guo H; Qin P; Hou W
    Mol Neurobiol; 2020 Aug; 57(8):3540-3551. PubMed ID: 32542593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
    Carroll N
    J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin dynamics in women receiving immediate or delayed transdermal estradiol after oophorectomy.
    Kamel EM; Maurer SA; Hochler MG; Hoffman DI; Rebar RW
    Obstet Gynecol; 1991 Jul; 78(1):98-102. PubMed ID: 1904568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women.
    Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J
    Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system.
    Nilsen J; Mor G; Naftolin F
    J Neurobiol; 2000 Apr; 43(1):64-78. PubMed ID: 10756067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.
    Vongpatanasin W; Tuncel M; Mansour Y; Arbique D; Victor RG
    Circulation; 2001 Jun; 103(24):2903-8. PubMed ID: 11413078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.